Home
Insmed

Insmed Market Share Analysis for June 2026

We work hard to understand the experiences of those living with serious diseases as we strive to deliver true change.

Health > Biotechnology and Pharmaceuticals

Domaininsmed.com

Year Founded1988

Employees1001 - 5000

Annual Revenue$200M - $500M

Insmed

Insmed (including company regionals)

insmed.com

See more website traffic and engagement information

Insmed Revenue up to June 2026 is 200M - 500M

revenue generated by Insmed top domains

Insmed top domains revenue over 3 years

Revenue for Insmed top domains

insmed.com200M - 500M

See more with Sales Intelligence

Insmed Stock price in June 2026

Insmed stock is traded under the ticker #INSM. Below you can review Insmed stock performance in the past 12 months up to June 2026

Total visits to Insmed's top domains

Understand Insmed market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

insmed.com49.4K

See more with Sales Intelligence

Avg. visit duration in Insmed's top domains

Analyze Insmed engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

insmed.com00:01:18

See more with Sales Intelligence

Avg. pageviews on Insmed's top domains

See how Insmed keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

insmed.com2.33

See more with Sales Intelligence

Insmed top competitors by domain

Top similar sites in June 2026, ranked by their affinity

incyte.comCompany NameIncyteEmployees1001 - 5000HQUnited States, Delaware, WilmingtonAnnual revenue> $1BTotal visits91.5KScience and Education > Biology

Top technologies used by Insmed

These are the website technologies, by industry, used by Insmed top domains

Payment & Currencies (10)

Cart Functionality

eCommerce (7)

WooCommerce

Advertising (6)

DoubleClick

Widget (5)

Twemoji

More Technologies

14

See all

News & Signals from Insmed

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInsmed Incorporated hired Samuele Butera as senior vice president, general manager, global respiratory on Jun 24th '26.Insmed Inc., a global biopharmaceutical company based out of Bridgewater, announced June 24 the appointment of Samuele Butera as senior vice president, general manager, global respiratory, effective immediately.

NewsInsmed Incorporated launched BRINSUPRI on Jun 23rd '26.The appointment comes at a pivotal time for Insmed as it continues the commercial launch of BRINSUPRI, pursues a potential label expansion for ARIKAYCE, and advances its treprostinil palmitil inhalation powder (TPIP) development program.

NewsInsmed Incorporated attended event 2026 American Thoracic Society (ATS) international conference on May 19th '26.At the 2026 American Thoracic Society (ATS) international conference, Insmed's presence featured a strong focus on Brinsupri (brensocatib), the first-to-market therapy for non-cystic fibrosis bronchiectasis (NCFB) and first-in-class dipeptidyl peptidase 1 (DPP1) inhibitor targeting neutrophilic inflammation.